Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

[Hereditary forms of ovarian cancer].

de Pauw A, Jolissaint L, Fréneaux P, Rouleau E, Stoppa-Lyonnet D, Buecher B.

Bull Cancer. 2012 Apr 1;99(4):453-62. doi: 10.1684/bdc.2012.1544. Review. French.

2.

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Casey MJ, Bewtra C, Lynch HT, Snyder C, Stacy M, Watson P.

Fam Cancer. 2013 Dec;12(4):719-40. doi: 10.1007/s10689-013-9651-x.

PMID:
23666231
3.

Familial breast and ovarian cancers.

Arai M, Utsunomiya J, Miki Y.

Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.

PMID:
15375703
4.

Genetic testing by cancer site: ovary.

Weissman SM, Weiss SM, Newlin AC.

Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2. Review.

PMID:
22846732
5.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
6.

Hereditary ovarian cancer.

Prat J, Ribé A, Gallardo A.

Hum Pathol. 2005 Aug;36(8):861-70. Review.

PMID:
16112002
7.

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK.

Mol Oncol. 2009 Apr;3(2):97-137. doi: 10.1016/j.molonc.2009.02.004. Epub 2009 Feb 21. Review.

8.

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.

American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists.

Obstet Gynecol. 2009 Apr;113(4):957-66. doi: 10.1097/AOG.0b013e3181a106d4.

PMID:
19305347
9.

[Inherited breast and ovarian cancers].

Gerdes AM, Ejlertsen B.

Ugeskr Laeger. 2006 Jun 12;168(24):2367-9. Danish.

PMID:
16822422
10.

Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.

Shaw PA, Clarke BA.

Surg Pathol Clin. 2016 Jun;9(2):307-28. doi: 10.1016/j.path.2016.02.002. Review.

PMID:
27241111
11.
12.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
13.
14.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.

Cancer. 2005 Dec 15;104(12):2807-16.

15.

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL.

Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.

16.

Pretest genetic counseling informs patients with BRCA mutation.

Printz C.

Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922. No abstract available.

17.

The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.

Komata D, Yahata T, Kodama S, Koyama Y, Takeda N, Tajima K, Makino H, Sato N, Muto I, Hatakeyama K, Tanaka K.

J Obstet Gynaecol Res. 2009 Oct;35(5):912-7. doi: 10.1111/j.1447-0756.2009.01090.x.

PMID:
20149041
19.

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.

PMID:
11759816
20.

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

Clin Genet. 2009 Mar;75(3):220-4.

PMID:
19263514

Supplemental Content

Support Center